Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis
Authors
Keywords
-
Journal
United European Gastroenterology Journal
Volume 9, Issue 10, Pages 1119-1127
Publisher
Wiley
Online
2021-12-07
DOI
10.1002/ueg2.12163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The changing scenario of hepatitis D
- (2021) Mario Rizzetto et al. JOURNAL OF HEPATOLOGY
- Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real life
- (2021) Tarik Asselah et al. LIVER INTERNATIONAL
- Endpoints and New Options for Treatment of Chronic Hepatitis D
- (2021) Anna S. Lok et al. HEPATOLOGY
- New therapies for hepatitis delta virus infection
- (2021) Dimitri Loureiro et al. LIVER INTERNATIONAL
- Long‐term study of hepatitis D infection at secondary care centers: the impact of viremia on liver‐related outcomes
- (2020) Habiba Kamal et al. HEPATOLOGY
- Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis Delta
- (2020) Dominique Roulot et al. JOURNAL OF HEPATOLOGY
- Bulevirtide: First Approval
- (2020) Connie Kang et al. DRUGS
- Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: A meta-analysis
- (2020) Aigerim Abdrakhman et al. ANTIVIRAL RESEARCH
- New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies
- (2020) Zhenfeng Zhang et al. JOURNAL OF HEPATOLOGY
- Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: Results from the HIDIT‐II study
- (2020) Birgit Bremer et al. LIVER INTERNATIONAL
- Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
- (2019) Heiner Wedemeyer et al. LANCET INFECTIOUS DISEASES
- GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
- (2019) Heiner Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Excellent safety and effectiveness of high dose myrcludex-b monotherapy administered for 48 weeks in hdv related compensated cirrhosis: a case report of three patients
- (2019) Alessandro Loglio et al. JOURNAL OF HEPATOLOGY
- The medical impact of hepatitis D virus infection in Uzbekistan
- (2019) Malika Khodjaeva et al. LIVER INTERNATIONAL
- Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
- (2018) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort
- (2018) Giuseppina Brancaccio et al. DIGESTIVE AND LIVER DISEASE
- Hepatitis delta-associated mortality in HIV/HBV-coinfected patients
- (2017) Charles Béguelin et al. JOURNAL OF HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)
- (2017) Anika Wranke et al. LIVER INTERNATIONAL
- Hepatitis delta infection in Italian patients: towards the end of the story?
- (2016) Tommaso Stroffolini et al. INFECTION
- Hepatitis delta virus infection in Romania: prevalence and risk factors
- (2015) Journal of Gastrointestinal and Liver Diseases
- Expanding consensus in portal hypertension
- (2015) Roberto de Franchis JOURNAL OF HEPATOLOGY
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- Rapid hepatitis B and hepatitis Delta virus RNA quantification from small-sized liver tissue samples
- (2014) Andrzej Taranta et al. JOURNAL OF CLINICAL VIROLOGY
- 160 HEPATITIS DELTA – STILL OF MAJOR CONCERN IN RUSSIA, DUE TO IMMIGRATION AND INTRAVENOUS DRUG USAGE: VIEW FROM LARGE SINGLE CENTER COHORT
- (2012) K.I. Yesmembetov et al. JOURNAL OF HEPATOLOGY
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started